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New approach to determine 
the healthy immune variations 
by combining clustering methods
Claire Liefferinckx1,2*, Zacharie De Grève3, Jean‑François Toubeau3, Hélène Perée4, 
Eric Quertinmont1, Vjola Tafciu1, Charlotte Minsart1,2, Souad Rahmouni4, Michel Georges4, 
François Vallée3 & Denis Franchimont1,2
Immune‑mediated inflammatory diseases are characterized by variability in disease presentation 
and severity but studying it is a challenging task. Defining the limits of a healthy immune system 
is therefore a prior step to capture variability in disease conditions. The goal of this study is to 
characterize the global immune cell composition along with their influencing factors. Blood samples 
were collected from 2 independent cohorts of respectively 389 (exploratory) and 208 (replication) 
healthy subjects. Twelve immune cells were measured in blood together with biological parameters. 
Three complementary clustering approaches were used to evaluate if variability related to the 
immune cells could be characterized as clusters or as a continuum. Large coefficients of variation 
confirmed the inter‑individual variability of immune cells. Considering all subset variations in an 
overall analysis, it appeared that the immune makeup was organized as a continuum through the 
two cohorts. Some intrinsic and environmental factors affected the inter‑individual variability of cells 
but without unveiling separable groups with similar features. This study provides a framework based 
on complementary clustering approach for analyzing inter‑individual variability of immune cells. Our 
analyses support the absence of clusters in our two healthy cohorts. Also, our study reports some 
influence of age, gender, BMI, cortisol, season and CMV infection on immune variability.
Abbreviations
BMI  Body mass index
CMV  Cytomegalovirus
CRP  C-reactive protein
DBSCAN  Density-based clustering
EBV  Epstein–Barr virus
GMM  Gaussian mixture model
IMIDs  Immune-mediated inflammatory diseases
PAM  Partition around medoids
PCA  Principal component analysis
tSNE  t-Distributed stochastic neighbour embedding
The immune system is a key component of human health, and any quantitative or qualitative dysregulation of it 
can result in infectious diseases, malignancy or immune-mediated inflammatory diseases (IMIDs)1. The most 
common IMIDs are psoriasis, type 1 diabetes, inflammatory bowel diseases or ankylosing spondylitis. These 
diseases are associated with a significant morbidity and reduce the patient’s quality of life. They also show a large 
and unpredictable variation in terms of presentation (age at diagnosis, location,…), severity (disease activity 
and progression) and response to  treatment2. So far, their clinical management is usually reactive and tailored 
to their clinical presentation and severity, which does not always allow to reverse tissue damage related to 
 inflammation3,4. In that regard, an improved knowledge of the human variation of the immune response could 
probably help to decipher some predictive variables related to the spectrum of severity of IMIDs, to switch from 
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a reactive management towards a personalized pro-active management that would prevent tissue damage and 
remodeling related to  inflammation5,6.
However, studying variations in disease presentation and severity regarding IMIDs is a challenging task due 
to the high variability of the immune response among these patients. Defining the limits of a healthy immune 
system is therefore a prior step to capture variability in disease conditions and several healthy cohorts have been 
published in this  perspective7–10. While many studies have investigated the inter-individual variability for each 
immune cell subsets separately, few have profiled the global immune cell composition and their interdependence 
in healthy  cohorts11–13. The clustering methods described in the medical  literature11,12 to capture this immune cell 
interdependence were mainly based on traditional K-means algorithm which lacks of robustness face to outliers 
and  noise14. Likewise, the evaluation metrics used for assessing the quality of the solution given by clustering 
algorithms were rarely applied, excepted the Silhouette  Index12. Hence, there is still an open debate on whether 
the immune system variations should be characterized as discrete groups or as a  continuum15.
The main goal of our study is to characterize the limits and the overall structure of the immune system 
variations in a large healthy cohort by leveraging different methods of clustering. In particular, we apply three 
complementary algorithms, on data gathered from both a base cohort and a replication cohort, and compute 
adequate metrics to evaluate the relevance of the groups. Our study also aims at analyzing the influence of some 
intrinsic and environmental factors on the immune composition, which is achieved by ensuring both strict 
inclusion/exclusion criteria, and a consistent and well-defined study design. We propose in that way a tagged-
factor clustering. Hence, the present work aims at presenting a combined clustering framework to better define 
the inter-individual variability of healthy immune system, which serves as a prior step to better understand the 
related variability in IMIDs.
Methods
Study populations. Strict conditions were applied to build a well characterized and homogeneous cohort. 
The study cohort (GEOCODE cohort) involved 389 healthy subjects prospectively included between October 
2016 and March 2018. The study was approved by the Ethics committee of Erasme Hospital, Brussels, Belgium 
(Reference number: P2015/425, date approval: 03/11/2015). All used methodologies were in accordance with 
approved guidelines and were performed in accordance with the Declaration of Helsinki. Each subject signed 
an informed consent. Inclusion criteria included age between 18 and 65 years, smoking-free status, no use of 
drugs excepted hormonal contraception or finasteride, benzodiazepine and proton-pump inhibitors, and to be 
in “good health” (see details in Supplementary methods). Exclusion criteria included participation of another 
family member to the present study (first–second–third degree), shift workers (chronic jet lag) or any following 
situations within the previous two weeks of inclusion: actively allergic disease, episode of temperature > 38 °C, 
dentist consultation or endoscopic operation, vaccination or steroid (systemic or topic) treatment. A second 
cohort (LIEGE cohort) was used to independently validate clustering results. This replicative cohort involved 
208 healthy subjects prospectively included between October 2018 and March 2020. The second cohort was 
approved by the Ethics committee of CHU Liège, Belgium (Reference number: 2017/214, date approval: October 
5, 2017). Again, all methodologies used for the replicative cohort were in accordance with approved guidelines 
and were performed in accordance with the Declaration of Helsinki. Each subject signed an informed consent.
Data collection and measurements. A case report form was completed for each subject before collec-
tion of blood samples to ensure that inclusion/exclusion criteria were encountered. Gender, age, height, weight, 
medical and familial history were collected. All blood samples (+ /− 40 ml) were collected between 07h30 and 
10h00 a.m. to standardize the circadian cycle after overnight fasting. A fresh EDTA tube was processed within 
the same day of blood collection for immunophenotyping. Details on immunophenotyping are presented in 
Supplementary methods. All immune cell counts were expressed by  mm3. Plasma and sera were aliquoted and 
stored at − 20  °C for later measurements of cytomegalovirus (CMV)/Epstein–Barr virus (EBV) serologies, 
C-Reactive Protein (CRP) level, cortisol, estradiol, progesterone, and testosterone. At the end of cohort constitu-
tion, all measurements were performed by batch of 20 samples over 4 weeks at the laboratory of Erasme Hos-
pital (LHUB-ULB). IgG CMV, IgG EBV, cortisol, estradiol, progesterone and testosterone were measured using 
an electro-chemiluminescent immunoassay (Cobas-Roche). EBV and CMV serologies were expressed as U/
ml and considered as positive if > 20 U/ml and > 1 U/ml, respectively. Cortisol and testosterone were expressed 
as nmol/l, while estradiol was expressed as ng/l, and progesterone as μg/l. C-Reactive protein (CRP) level was 
measured using immunoturbidimetric test (Cobas- Roche), and expressed in mg/l.
Clustering and tagged‑factor clustering. The GEOCODE dataset comprised initially 389 individuals 
represented by 12 different immune cells, whereas the LIEGE dataset was made of 208 individuals described by 
10 different immune cells (consisting in a subset of the 12 GEOCODE different immune cells, see Supplemen-
tary methods for the list of considered immune cell subsets). Three complementary clustering methodologies 
were chosen to strengthen the confidence in the obtained results. Partition Around Medoids (PAM)16 was firstly 
applied as it represents a well-known algorithm with some interesting properties (such as, e.g., a better robust-
ness to outliers and noise compared to the traditional K-means  algorithm14) but it cannot find non-convex 
clusters. Also, the number of clusters has to be fixed a priori. To alleviate limits related to PAM, density-based 
clustering, and more particularly the DBSCAN17 technique, has also been employed. The main idea consists in 
partitioning the input space by separating dense from sparse zones. The algorithm is in that way able to detect 
clusters of arbitrary shapes. Finally, Gaussian Mixture Model (GMM) clustering18, belonging to the family of 
model-based clustering techniques, was employed in order to ascertain our results.
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The two datasets were then augmented by tagging intrinsic and environmental factors. By doing so, we aim at 
revealing structure in the dataset which could be possibly induced by the consideration of such factors. Briefly, 
we visually assessed the clustering tendency of a dataset by applying a Principal Component Analysis (PCA)19 
and t-distributed stochastic neighbor embedding (tSNE)20, and we tagged the dataset according to the predefined 
values of the studied intrinsic/environmental factors. The dataset was first tagged with regards to each factor 
separately followed by a multi-factor tagging in which all possible combinations of intrinsic/environmental 
factors were tested. In total, 31 combinations were investigated. This tagged-factor clustering was developed 
to visually unveil the potential presence of substructure in the GEOCODE cohort even though first clustering 
methods suggest a one cluster solution.
Models calibration and evaluation methods. Evaluating partitions obtained by clustering approaches 
faces two main challenges. First, the ground truth is usually non-accessible to assess the quality of a partition, so 
that the ‘true’ number of clusters is unknown in practice. Second, the complete absence of structure in a dataset, 
which corresponds to a situation where a single cluster solution is the most suited, is not easily quantified by 
common clustering evaluation methods, especially in the case of partitional algorithms. To deal with these two 
challenges, three different evaluation metrics were employed for assessing the quality of the solution given by 
the partitional clustering algorithms (the PAM algorithm in this case) and infer the correct number of clusters, 
i.e. the Silhouette Index, the Gap Statistic, as well as a Cluster Stability Analysis. On the other hand, an ad-hoc 
evaluation criterion was provided for the DBSCAN and GMM clustering techniques, since these approaches are 
inherently able to suggest the best number of clusters. More details regarding the data pre-processing (including 
details on the management of missing data), the clustering methodologies, and model calibration and evalua-
tion methods are presented in Supplementary Methods. Clustering analyses, evaluation methods and associated 
graphs were performed using R Software version 3.6.1 (R Core Team (2020). R: A language and environment 
for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. URL https:// www.R- proje ct. 
org/).
Statistical analysis. Mann–Whitney test was used for comparing univariate distributions of non-paramet-
ric and continuous variables. Results were therefore expressed as median with interquartile range (IQR 25–75). 
An univariate general linear model was used to analyze the variance of each leukocyte subset (dependent varia-
ble) by taking into account of independent variables such as sex, use of pill, age and BMI). Bonferroni correction 
was used for correcting multiple testing. Also, independent variables were integrated in linear regression and 
the coefficient of determination  (R2) was calculated for each independent variable. This coefficient reflects the 
proportion of the variance in the dependent variable that is predictable from the independent variables. Pearson 
χ2 test was used to compare categorical variables. Pairwise Spearman’s rank correlation coefficient was used for 
quantifying correlation between non-parametric variables. Significant difference was set for p-value < 0.05. The 
analyses were performed with SPSS version 20.0 (SPSS Inc., Chicago, IL, USA).
Results
Study cohort and related characteristics. The GEOCODE cohort, the main study cohort, included 389 
individuals distributed as 237 females and 152 males. The median age (29 years, IQR 25–39) was similar regard-
less of gender but BMI was higher in males (p < 0.0001). Seven percent (n = 26) of subjects were not of European 
origin. A familial history of IMIDs was found in 5.7% (n = 22) while a personal history of allergy was found in 
4.1% (n = 16). Among females, 66% (n = 157) reported contraceptive pill use and 5 menopausal females used 
hormonal substitution. Aside from contraceptive pill, a total of 3.3% (n = 13) of the subjects were taking author-
ized drugs (See Supplementary methods). None of the subjects was active smoker. Serology for EBV and CMV 
were positive in 90.1% (n = 345/383) and 53.9% (n = 207/384), respectively.
Inter‑individual variability of the immune composition in unstimulated conditions. Regarding 
cell count for each leukocyte subset, a large inter-individual variability was observed with a coefficient of vari-
ation ranging from 30 to 100% within the two cohorts (Supplementary Fig. 1). In the specific case of basophil 
count in GEOCODE cohort, the coefficient of variation has to be interpreted with regards to methodology (See 
Supplementary methods). Likewise, although the normal CD4/CD8 ratio for a healthy subject is believed to be 
around 2, CD4/CD8 ratios observed in our cohort exposed a large range between 0.1 and 12.4. Multiple positive 
correlations between each two leukocyte distributions were observed (Fig. 1A). With age and BMI as covari-
ates, monocyte and NK cells counts were higher in males while T cells (including CD4 + T cells) were higher in 
females (Table 1). However, after additional correction for contraceptive pill use, only monocyte and NK cell 
distributions remained influenced by gender (Table 2). Considering females, only CD4 + T cells counts was sig-
nificantly higher with use of contraceptive pill (Table 3).
The inter‑individual variability of circulating immune cells is organized as a continuum. The 
first 3 Principal Components from the PCA of the study cohort allowed to depict 48.3% of the overall variability 
(Fig. 2A) but no particular tendency in terms of structure was observed using that qualitative visual criterion. 
We confirmed that first hypothesis quantitatively by applying clustering techniques on the whole 12-dimen-
sional study cohort, and by interpreting the corresponding evaluation metrics. Figure  2B shows the average 
Silhouette Indices obtained by running PAM with an increasing number of clusters K. It is shown that decreasing 
the number of clusters leads to higher (and thus better) Silhouette Indexes, thus suggesting that the data can-
not be clustered (since even the quality of the two-cluster solution is quite low). However, Silhouette index is by 
definition not able to confirm a lack of structure in a given dataset. In that regard, two other metrics were com-
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puted on the PAM results in order to confirm a possible single-component structure. Figure 2C shows the Gap 
Statistic as a function of the number of clusters. Interestingly, a solution with one single cluster, which maximizes 
the Gap Statistic, was suggested in this case. Figure 2D depicts the results of the Cluster Stability Analysis, for 
which 100 random subsamples of the original dataset have been clustered and compared using the Jaccard Index. 
According to Ben-Hur et al.21, the correct number of clusters can be found by identifying the CDF with the most 
pronounced step. Since such a step was not observed in our results, the Cluster Stability Analysis also suggested 
a single component structure for the GEOCODE cohort.
A second and independent cohort, namely LIEGE cohort, was used to confirm this single cluster solution 
(Supplementary Fig. 2). The phenotypic characteristics of this second cohort were compiled in Supplementary 
Table 1.
The two other clustering approaches, namely DBSCAN (Fig. 3) and GMM clustering (see Supplementary 
Fig. 3), both confirmed this single cluster structure with both GEOCODE and LIEGE cohorts, thereby showing 
the consensus in terms of number of clusters between PAM, DBSCAN and GMM clustering. It should be noted 
that, more generally and if needed, partitions obtained by using different clustering algorithms may be combined 
Figure 1.  Correlation of baseline immunological parameters and phenotype (age, BMI) at baseline. (A) 
Correlation between the all leukocyte subsets. (B). Correlation between the all leukocyte subsets and phenotypic 
characteristics such as age, BMI, hormones and CRP. Spearman’s rank correlation was used. If the correlation 
was not significant, a blank square is shown. Colored squares indicate when a correlation was significant 
(p < 0.05).
Table 1.  Leukocyte proportions according to gender with age and BMI in covariates. p-values are highlighted 
in bold when significant
Female (n = 237) Male (n = 152) p-value
Neutrophils 3100 (2500–3850) 3000 (2500–3700) 0.17
Lymphocytes 1866 (1586–2231) 1830 (1495–2158) 0.32
Basophiles 0 (0–0) 0 (0–0) –
Eosinophils 100 (100–200) 100 (100–200) 0.25
Monocytes 400 (400–500) 500 (400–600) < 0.001
T cells 1483 (1185–1772) 1365 (1073–1644) 0.012
CD4 + T cells 912 (744–1154) 786 (645–998) < 0.001
CD8 + T cells 456 (362–588) 466 (328–602) 0.87
CD4 + CD8 + T cells 5 (3–14) 3 (2–13) 0.85
CD4-CD8- T cells 48 (31–76) 52 (32–82) 0.24
NK cells 175 (124–247) 228 (174–331) < 0.001
B cells 180 (130–242) 188 (130–256) 0.65
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into a robust consensus clustering result using other approaches as described in the  literature22,23. The distances 
of each object to its nearest neighbor sorted in ascending order further demonstrated that individuals tend to 
be closely aggregated together, in both cohorts. Even if several individuals were more distant from the others, 
they do not represent a convincing well-defined separate cluster (Fig. 3).
Effects of intrinsic and environmental factors on the inter‑individual variability of the immune 
composition. Intrinsic factors were age, gender, hormones (testosterone, progesterone, estradiol and corti-
sol), BMI and history of allergy while environmental factors were season at inclusion, use of contraceptive pill 
and, EBV and CMV serologies. Estradiol was negatively correlated with several leukocyte subsets, i.e., lympho-
cytes, CD4 + T cells, and NK cells. Testosterone was positively correlated with monocytes and NK cells, and 
negatively correlated with CD4 + T cells. No correlation was found between immune cells and progesterone. 
While the median age was 29 years, age was negatively correlated with all lymphocyte distributions, excepted 
CD4 + T cells and CD4 + CD8 + T cells. In this latter case, CD4 + CD8 + T cells were positively associated with age 
(Fig. 1B). Although no subjects with acute allergies were included, eosinophil count was higher in subjects with 
allergic history, p = 0.009 (median: 200 (IQR 100–350) vs. median 100 (IQR 100–200)). Positive EBV serology 
had no influence on leukocyte distributions. On the contrary, impact of CMV status on lymphocyte repertoire 
was significant even with age was considered as covariate. A positive CMV serology was associated with a higher 
median for T cells (median 1485, IQR (1196–1778) vs. median 1419 IQR (1085–1671), p = 0.025) and CD8 + T 
cells (median 525, IQR (377–638) vs. median 432 IQR (311–533), p = 0.0001) (Fig. 4).
BMI and cortisol represented the two main factors explaining variance of the different circulating immune 
cells. However, depending of the leukocyte subset, the type of factors and their influence vary. For instance, 
the history of allergy represents the best factor explaining eosinophil variance while gender is the best factor 
explaining NK cell variance. The influence of seasons on immune cell variance was marginal for all leukocyte 
subsets but CD4 + CD8 + T cells. In this latter case, the level of CD4 + CD8 + T cells was significantly higher dur-
ing Autumn and Winter before decreasing during Spring and Summer. Nonetheless, all available factors jointly 
Table 2.  Leukocyte proportions between males and females not using contraceptive pill with age and BMI in 
covariates. p-values are highlighted in bold when significant
Male (n = 152) Female w/o use (n = 77) p-value
Neutrophils 3000 (2500–3700) 3100 (2500–3800) 1
Lymphocytes 1830 (1495–2158) 1781 (1488–2080) 1
Basophiles 0 (0–0) 0 (0–0) –
Eosinophils 100 (100–200) 100 (100–200) 1
Monocytes 500 (400–600) 400 (400–500) 0.025
T cells 1365 (1073–1644) 1437 (1071–1657) 1
CD4 + T cells 786 (645–998) 813 (677–1069) 1
CD8 + T cells 466 (328–602) 416 (300–543) 0.6
CD4 + CD8 + T cells 3 (2–13) 5 (3–14) 1
CD4-CD8- T cells 52 (32–82) 44 (30–67) 1
NK cells 228 (174–331) 178 (131–249) 0.001
B cells 188 (130–256) 175 (116–239) 1
Table 3.  Leukocyte proportions among females using or not contraceptive pill with age and BMI in covariates. 
p-values are highlighted in bold when significant
Use (n = 171) No use (n = 77) p-value
Neutrophils 3200 (2500–4000) 3100 (2500–3800) 1
Lymphocytes 1931 (1647–2350) 1781 (1488–2080) 0.22
Basophiles 0 (0–0) 0 (0–0) –
Eosinophils 100 (100–200) 100 (100–200) 0.67
Monocytes 400 (400–500) 400 (400–500) 1
T cells 1518 (1278–1849) 1437 (1071–1657) 0.92
CD4 + T cells 941 (772–1171) 813 (677–1069) 0.03
CD8 + T cells 500 (386–616) 416 (300–543) 0.53
CD4 + CD8 + T cells 5 (3–14) 5 (3–14) 1
CD4-CD8- T cells 53 (32–84) 44 (30–67) 1
NK cells 173 (118–247) 178 (131–249) 1
B cells 186 (139–243) 175 (116–239) 1
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considered were found to explain less than 20% of the overall variance of the different circulating immune cells 
(Supplementary Fig. 4).
The combined effect of factors does not induce the emergence of clusters. Although the overall 
structure of circulating immune cells was organized as a continuum, the impact of intrinsic factors (gender, age 
and BMI) or extrinsic factor (CMV/EBV status) could unveil a sub-structure with emergence of discrete groups. 
First, the influence of factor was analyzed by tagging the dataset with each intrinsic and extrinsic factor sepa-
rately. Second, all possible combinations of intrinsic/environmental factors were tested by a multi-factor tagging 
(see “Methods” section). From the 31 resulting combinations, none allowed discovering the emergence of dis-
crete groups. Figure 5A illustrates 3-dimensional PCAs of the study cohort as well as tSNE with tagged individu-
als according to age, gender, EBV/CMV status separately. No structure tends to visually appear. Interestingly, the 
median age of the replicative cohort was higher than the study cohort (29 years vs. 51 years). Despite this median 
older age in the replicative cohort, a substructure did not appear in this case as well. Figure 5B combines the 
age and CMV factors in a 3-dimensional PCA and tSNA. Again, no shift in immune variability seems to appear.
Discussion
This study provides a methodological framework for capturing the inter-individual variability of the circulating 
immune cells in a significant cohort of healthy subjects and the inter-relationships between these immune cells. 
By leveraging complementary clustering methods, we observed that the integrated variabilities of circulating 
immune cells are organized as a continuum since no clusters could be identified. A second and independent 
cohort was used to confirm the results, thus ensuring the robustness of our methodology. Moreover, a tagged-
factor clustering based on intrinsic/environmental factors (gender, age, BMI, EBV and CMV status) did not allow 
to unveil the emergence of clusters. Interestingly, aside from clustering analyses, we reported that gender (and 
related hormones), BMI, cortisol, EBV/CMV status and seasons have some influence immune variations. Also, 
Figure 2.  Clustering approaches applied to GEOCODE study cohort. (A) Three-dimensional PCA of the 
study was used as a qualitative visual criterion. (B) The graph shows the average silhouette indices obtained 
by running PAM with an increasing number of clusters K. For each value of K, 20 instances of the PAM 
algorithm were run with a random initialization of centroids, in order to mitigate the effect of local minima. The 
corresponding solutions are represented by black circles, whereas the best solutions for each K, i.e. the partitions 
which maximize the Silhouette Index, are connected by a plain red line. (C) The graph shows the Gap Statistic 
as a function of the number of clusters. For each value of K, the Gap Statistic was computed by comparing the 
clustering solution obtained on the dataset with partitions extracted from 200 unstructured datasets randomly 
generated. (D) The graph shows the results of the Cluster Stability Analysis, for which 100 random subsamples 
of the original dataset have been clustered and compared using the Jaccard Index. Graphs were performed using 
R Software version 3.6.1
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we observed that gender difference in CD4 + T cells seemed more related to the use of contraceptive pill than 
gender itself. Overall, less than 20% of the overall variability of immune cells was explained by these intrinsic 
and environmental factors.
So far in the literature, the inter-individual variability of immune cells has been mainly analyzed for each 
immune subset separately, which prevented to capture the complexity of inter-relationships between immune 
subsets and thus to have a global understanding of human immune system  variation12,15. This question is how-
ever important to properly define individuals with outlier measurements, not only for one leukocyte subset but 
for the combination of all of them. Through a robust clustering methodology including three complementary 
approaches, we observed that the leukocyte subsets were organized as a continuum and we replicated these obser-
vations in an independent cohort. This absence of clusters of individuals sharing similar variation of immune cell 
composition is aligned with recent  findings12,13. Likewise, the homogenous blood cell composition observed in 
Figure 3.  DBSCAN clustering approach. (A) Graphs suggested that the data objects were noisy points for 
the two cohorts, since the obtained number of clusters at the optimal value of ε is zero. (B) Graphs show that 
individuals tend to be closely aggregated together. Graphs were performed using R Software version 3.6.1
Figure 4.  Distributions of immune cells according to CMV serology. (A) T cell counts according to CMV 
serology (n = 207 seropositive subjects, n = 177 seronegative subjects). (B) CD8 + T cell and CD4-CD8- T cell 
counts according to CMV serology (n = 207 seropositive subjects, n = 177 seronegative subjects). Graphs were 
performed using SPSS version 20.0
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our cohorts reflects a balanced homeostasis expected in healthy subjects. As gender, age, CMV status contribute 
to shape the immune inter-individual  variability7,24–27, we integrated these factors (alone and in a combinatorial 
analysis) to ensure that clusters do not emerge in some specific situations. Overall, our results give more argu-
ments to reasonably exclude, in healthy subjects, the existence of discrete groups including individuals with 
similar variation of immune cell composition.
Several recent studies have described the large variability of the immune system in healthy  subjects7–10. 
These studies, including ours, respond to the need of defining the boundaries of healthy immune  system10 and 
represent a precondition before capturing inter-individual variability of IMIDs. Overall, numerous intrinsic 
and extrinsic factors contribute to explain the observed variability between healthy individuals. By contrast 
to other healthy cohorts, we applied stricter inclusion/exclusion criteria to rule out the impact of well-known 
factors on this  variability10,28. For instance, an active smoking status was prohibited as it is well described that 
tobacco largely influences immune cell  frequencies29. Likewise, the use of almost all drugs was prohibited (see 
“Methods” section). However, due to the frequency of contraceptive pill use in healthy women, this drug was 
accepted and we took opportunity of analyzing how contraceptive pill can impact the immune variability. This 
hormonal drug seems to significantly impact the lymphocytes and most specifically T cells. Interestingly, the 
gender difference in CD4 + T cells, recently  reported27, disappeared when females not using contraceptive pill 
were compared to males which may suggest that the contraceptive pill could impact CD4 + T cells. Indeed, we 
observed that use of contraceptive pill was associated with a higher absolute number of circulating CD4 + T cells. 
However, due to the complex influence of hormones (both endogenous and synthetic) on immune system, it is 
difficult to known whether these higher levels of circulating CD4 + T cells actually represent a susceptibility risk 
for the development of  IMIDs30,31.
CMV is known to largely influence T  cells32 but its impact (alone or with other factors) on the inter-rela-
tionships of immune subsets has been less explored. As seropositive CMV status combined with age have been 
associated with shifts in  immunotypes12, we explored the combined effect of these factors on the emergence of 
discrete groups but we did not unveil clusters. By contrast to CMV, influence of EBV on immune cell frequencies 
has not been described in the literature. One explanation could be the very high prevalence of EBV in popula-
tions, making it difficult to compare seropositive and seronegative individuals. While the median age of our 
study was quite young, i.e., 29 years, EBV serology was positive in 90.1% of cases which is in line with reported 
epidemiologic  data33.
The proposed study has some limitations which can be discussed. Firstly, due to our strict criteria of inclusion, 
our study cohort is characterized by a narrowed range of age which precluded any evaluation of the influence 
of immune senescence on the emergence of clusters over time. Likewise, the opposite correlations between age 
and, CD4 + T cell and CD8 + T cell subsets appeared contradictory. However, it is described in the literature that 
CD4 + T cells and CD8 + T cells behave differently in response to  aging34. This dynamic behavior has not been 
captured due to the young median age of our GEOCODE cohort and could explain this apparent discrepancy. 
Figure 5.  Three-dimensional PCAs of the GEOCODE study cohort with intrinsic and extrinsic factors. (A) 
Three dimensional PCAs and tSNE of the GEOCODE study cohort are depicted with tagged individuals 
according to age, gender, EBV/CMV status separately. (B) Three-dimensional PCA and tSNE of the GEOCODE 
study cohort is depicted with tagged individuals according to combination of the age and CMV factors. Graphs 
were performed using R Software version 3.6.1
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Nonetheless, the older age of individuals in the replicative cohort allowed us to partly exclude the involvement 
of age on a potential shift. Secondly, our analysis on inter-relationships between immune cells included 12 
leukocyte subsets, which represents only a small part of all circulating leukocyte subsets. We therefore cannot 
exclude that the addition of other leukocyte subsets unveils clusters. However, it should be noted that others 
research teams did not find clusters despite the use of such additional leukocyte  subsets12,13. Thirdly, a significant 
part of the overall variability could be explained by the genetic makeup of  individuals9,26,35 and the influence 
of  microbiota25,36, but these factors were not available in this study. Finally, our data was restricted to analyze 
the variations of leukocyte subset distributions. In that regard, the variations in the transcriptional and transla-
tional profiles of leukocyte subsets as well as variations in the functional capacity in response to immunological 
stimulation were not investigated.
On the other hand, several strengths can be highlighted. Firstly, the study cohort had significant size, i.e., 
389 healthy subjects, with very few missing data (only few CMV/EBV serologies were missing) and based on 
strict criteria of inclusion and exclusion, which gave high confidence in the quality of data and precluded any 
substantial influence of external factors on the immune inter-individual variability such as the presence of a latent 
infection, a latent IMID or the influence of drugs. Secondly, a strict standardization was applied for immune 
cells measurements (See Supplementary methods) which reduced technical variability. Finally, the absence of 
discrete groups in clustering analysis remains a challenging point because it is difficult to firmly prove it (See 
“Methods” section). However, the use of three complementary clustering approaches in combination with rel-
evant evaluation metrics, i.e., silhouette index, gap statistic, cluster stability analysis and qualitative visual human 
evaluation, alleviate this issue and strengthen our results. In addition, we replicated our results in a second and 
independent (LIEGE) cohort.
In conclusion, our study provides a framework based on complementary clustering approach for analyzing 
inter-individual variability of immune cells and confirms the absence of clusters in our two healthy cohorts. 
Also, our study reports some influence of age, gender, BMI, cortisol, season and CMV/EBV infections on the 
distribution of peripheral immune cells.
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